Marcel Bekkenk

professor in dermatology, special interest in skin cancer, e-health and pigment disorders. Amsterdam UMC. Music lover and father of 3 kids. Views are my own.

[Mariette Labots @DrMarietteLabo]

🥁Mooie vacature bij de oncologie en dermatologie voor een #promovendus #artsonderzoeker #PhD🎓💡 @amsterdamumc en @CancerCenterAms!🤗
#melanoom #immuuntherapie #dermatologie #checkpointremmers #vitiligo
https://t.co/tzEp4WIinP

[Marcel Bekkenk @mbekkenk]

@TheExtremeMusi1 The Cult 24th of June 2025 in Amsterdam

[NEJM @NEJM]

Presented at #ASCO24:

Among patients who received two 3-week cycles of neoadjuvant ipilimumab and nivolumab, the 12-month event-free survival was 83.7%, as compared with 57.2% among those who received only adjuvant therapy. Full NADINA trial results: https://t.co/ZxWxo2qgNy

[Marcel Bekkenk @mbekkenk]

@kluizenares @PleegmamaLiv Zou zeggen: ga naar een dermatoloog, die is de specialist van de huid. Niet de fysiotherapeut…

[vpro @vpro]

In hun nieuwe serie reizen @jellebc en @RubenTerlou naar Centraal-Azië, ooit het knooppunt van de wereldmacht en nu opnieuw onder de aandacht bij China en Rusland. 'Langs de nieuwe zijderoute' zie je vanaf 5 maart elke zondag 20.20 uur op NPO 2. https://t.co/JIACrXzt7E

[Marc Besselink @MarcBesselink]

Good news for #patients and #cancer #research in #Amsterdam and beyond!

Intensified collaboration between ⁦@amsterdamumc⁩ & ⁦@NKI_nl⁩ https://t.co/YVJXN73SIF

[JAMA Oncology @JAMAOnc]

This study of 771 ipilimumab-nivolumab-treated melanoma patients shows worse PFS+OS for patients whose irAEs were treated with second-line immunosuppression compared to those managed with steroids only, irrespective of type of second-line immunosuppression https://t.co/KKjdoVvzBV

[The ASCO Post @ASCOPost]

Phase II Trial Reports High Response Rates With Neoadjuvant Cemiplimab in Cutaneous Squamous Cell Carcinoma https://t.co/TcQxxXOYL6 #skcsm #SCC #ESMO22 #oncology #immunotherapy

[NEJM @NEJM]

In two phase 3, double-blind, placebo-controlled trials, the Janus kinase inhibitor ruxolitinib showed superiority to vehicle control in facial repigmentation of vitiligo. https://t.co/zgkUMYHtIO

[ESDR @ESDRorg]

Good morning! We hope you enjoyed the #ESDR2022 Welcome Networking Reception last night!

[ESDR @ESDRorg]

The ANGLES 1 session will be interactive, participate to the poll here:
https://t.co/xexWtb144b

Title: Early Detection of Cancer: Man vs Machine
Date: Thursday 29 September - 14.30-15.00 CET
@susana_puig Giuseppe Argenziano @derm_scientist

[frans weisglas @fransweisglas]

Beste @MinPres @Minister_FIN @WBHoekstra @carolaschouten @hermans_sophie @PieterHeerma @jpaternotte @gertjansegers :wilt u het onderstaande - inclusief de duizenden reacties- ook op de agenda van het #Catshuisberaad van vandaag zetten.Dank! / cc @ministerVWS @ministerLZS @MinVWS

[ESDR @ESDRorg]

It is time to take advantage of our early rates for the 51st Annual ESDR Meeting!
Register today and join us in Amsterdam this autumn!
https://t.co/jYaREi8iuM

[Marcel Bekkenk @mbekkenk]

https://t.co/qjfGMXDvBb

[Marcel Bekkenk @mbekkenk]

@SaurPoints @ginger_worrier @SteHorton @frankcottrell_b Correct, lyrics of “a New England” by Bragg. Although he mentions satellites and not meteorites of course, therefore space hardware.

[Marcel Bekkenk @mbekkenk]

Ready for the first evening of @billybragg in Amsterdam. Me and billy go way back! First concert I saw him in Melkweg around 1991. Can he still play the old songs?

[ESDR @ESDRorg]

ESDR2022 will be run as a face-to-face event.
We will continue to monitor the pandemic situation in The Netherlands. We recognise some delegates would prefer not to travel to the ESDR meeting, therefore, options are available:
Read the full article: https://t.co/hKagv6hddK

[International Psoriasis Council @IpcPs]

The @ESDRorg is accepting abstracts for their upcoming 51st Annual Meeting in Amsterdam. The deadline to submit is Friday, May 27 and travel grants are available. Learn more: https://t.co/WImQoftjJf

[Masha Cherepkova @m_cherepkova]

A female biologist with 4 kids has fled Ukraine 🇺🇦 and now is looking for a research position in the Netherlands 🇳🇱. She is experienced with molbio and is getting her second degree in Bioinformatics. Please RT and contact me or @MrsElenaMelnik directly, if you can help